<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="30207">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02042417</url>
  </required_header>
  <id_info>
    <org_study_id>INRatio_CoaguChek</org_study_id>
    <nct_id>NCT02042417</nct_id>
  </id_info>
  <brief_title>Comparison of POC-test-equipment With the Laboratory</brief_title>
  <official_title>Comparison of POC-test-equipment With the Standard Method (Laboratory) at ICU-patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of Vienna</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of Vienna</source>
  <oversight_info>
    <authority>Austria: Ethikkommission</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      We compare two POC-tests (INRario2 and CoaguChek) for the INR with the laboratory.
      Therefore, we take bloodsamples (capillary and venous blood) and put it on the tool. After
      the measuring, a number is shown = INR.

      We develop a Bland-Altman-plot for the correlation between the tool value and the laboratory
      value to illustrate the applicability in the clinical daily routine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Including criteria: ICU-patients from 18-99 years
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>February 2014</start_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic</study_design>
  <primary_outcome>
    <measure>Comparison of POC-test-equipment with the standard method (laboratory) at ICU-patients</measure>
    <time_frame>12 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>outcome measure: Bland Altman plot</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <condition>INR-POC-testing</condition>
  <arm_group>
    <arm_group_label>INRatio2 and CoaguChek</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>one measuring per tool, in case of error: one repetiton</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>INRatio2 and CoaguChek</intervention_name>
    <arm_group_label>INRatio2 and CoaguChek</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        18-99 years, ICU patients

        Exclusion Criteria:

        Lupus erythematodes Anti-Phospholipid-Antik√∂rper
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Reinhard Hahn, MD</last_name>
    <phone>+431 40400</phone>
    <email>reinhard.hahn@meduniwien.ac.at</email>
  </overall_contact>
  <location>
    <facility>
      <name>MUVienna</name>
      <address>
        <city>Vienna</city>
        <zip>1090</zip>
        <country>Austria</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Reinhard Hahn, MD</last_name>
      <phone>+43 1 40400</phone>
      <email>reinhard.hahn@meduniwien.ac.at</email>
    </contact>
    <contact_backup>
      <last_name>Nitaya Lebl</last_name>
      <email>n0942382@students.meduniwien.ac.at</email>
    </contact_backup>
    <investigator>
      <last_name>Reinhard Hahn, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Austria</country>
  </location_countries>
  <verification_date>January 2014</verification_date>
  <lastchanged_date>January 20, 2014</lastchanged_date>
  <firstreceived_date>January 20, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of Vienna</investigator_affiliation>
    <investigator_full_name>Reinhard Hahn</investigator_full_name>
    <investigator_title>MD</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
